RP Management

Latest statistics and disclosures from RP Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BHVN, CYTK, BCRX, VIRX, and represent 100.00% of RP Management's stock portfolio.
  • Added to shares of these 1 stock: CYTK (+$53M).
  • Started 1 new stock position in CYTK.
  • RP Management was a net buyer of stock by $53M.
  • RP Management has $179M in assets under management (AUM), dropping by -0.74%.
  • Central Index Key (CIK): 0001507673

Tip: Access up to 7 years of quarterly data

Positions held by RP Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for RP Management

RP Management holds 4 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Biohaven (BHVN) 57.0 $102M 2.9M 34.71
 View chart
Cytokinetics (CYTK) 29.7 $53M NEW 980k 54.18
 View chart
BioCryst Pharmaceuticals (BCRX) 13.3 $24M 3.8M 6.18
 View chart
Viracta Therapeutics (VIRX) 0.0 $2.0k 3.7k 0.54
 View chart

Past Filings by RP Management

SEC 13F filings are viewable for RP Management going back to 2018

View all past filings